New trial provides 'no indication' ivermectin is 'clinically useful' in treating COVID-19
A large new trial has reportedly found no indication ivermectin is useful in treating COVID-19 patients.
The trial of almost 1,400 COVID-19 patients at risk of severe disease found the drug failed to reduce hospital admissions, according to The Wall Street Journal. In the trial, half the patients were prescribed ivermectin pills for three days, while the others received a placebo. The report noted this was the largest trial testing the effectiveness of ivermectin in treating COVID-19 so far.
"There was no indication that ivermectin is clinically useful," Edward Mills, a lead researcher on the study, told the Journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Peter Hotez of the National School of Tropical Medicine at Baylor College of Medicine also reviewed the findings and told the Journal they should "really help put to rest ivermectin and not give any credibility to the use of it for COVID-19."
The FDA hasn't approved ivermectin to treat COVID-19, and the agency has said that "currently available data do not show ivermectin is effective against COVID-19."
Still, ivermectin has been promoted as a potential treatment for COVID-19 by podcaster Joe Rogan, among others. Last year, Rogan said he took ivermectin when he contracted the coronavirus.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Why more and more adults are reaching for soft toys
Under The Radar Does the popularity of the Squishmallow show Gen Z are 'scared to grow up'?
By Chas Newkey-Burden, The Week UK Published
-
Magazine solutions - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Magazine printables - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published